>>Signaling Pathways>> Microbiology & Virology>> Enterovirus>>DC07090 dihydrochloride

DC07090 dihydrochloride

Catalog No.GC70549

DC07090 dihydrochloride 는 저독성, 강력성, 가역성, 경쟁성 비펩티드기인 장내 바이러스 71 3C 프로테아제 억제제로서 IC50과 Ki 값은 각각 21.72 μM과 23.29 μM이다.

Products are for research use only. Not for human use. We do not sell to patients.

DC07090 dihydrochloride Chemical Structure

Cas No.: 1158264-37-9

Size 가격 재고 수량
5 mg
US$149.00
재고 있음
10 mg
US$243.00
재고 있음
25 mg
US$491.00
재고 있음
50 mg
US$788.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
DC07090 dihydrochloride is a low toxicity, potent, reversible and competitive non-peptidyl human enterovirus 71 3C protease inhibitor with an IC50 and a Ki value for 21.72 μM and 23.29 μM. DC07090 dihydrochloride could also inhibit coxsackievirus A16 (CVA16) replication with an EC50 value of 27.76 μM.

DC07090 dihydrochloride forms stable hydrogen-bonding interactions with the main chains of S128, G145, G164 and hydrophobic interactions with F25, L125, L127 and F170. DC07090 dihydrochloride (0.01~10 μM) shows micromolar potency against EV71 3Cpro. DC07090 dihydrochloride exhibits a highly inhibitory potency on EV71 replication with an EC50 value of 22.09 μM. DC07090 dihydrochloride inhibits CVA16 with an EC50 value of 27.76 μM[1].

References:
[1]. Ma GH, et al. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening. Eur J Med Chem. 2016 Nov 29;124:981-991.

리뷰

Review for DC07090 dihydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for DC07090 dihydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.